Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute (CA252010)
  • U.S. Department of Veterans Affairs (I01 BX005267, VA 150CU000182)
  • LUNGevity Foundation (2022-14)
  • Melanoma Research Alliance (MRA 689853)

This publication has 37 references indexed in Scilit: